#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1126	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1103	54.2	0	.	p	.	0	K29T	NONSYN	85	87	AAG	327	329	ACG	65;62;63	A;C;G	65;62;63	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1126	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1103	54.2	0	.	p	.	0	T209S	NONSYN	625	627	ACT	867	869	TCT	43;42;42	T;C;T	43;42;42	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	4236	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1241	162.9	1	SNP	p	R234F	1	.	.	700	702	TTC	730	732	TTC	193;186;186	T;T;C	192;186;186	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	4236	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1241	162.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1030	1032	CGT	184;187;188	C;G;T	182;184;186	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	4236	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1241	162.9	0	HET	.	.	.	T180C	.	180	180	T	210	210	T	121	T,C	70,43	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	4236	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1241	162.9	0	HET	.	.	.	C261T	.	261	261	C	291	291	C	152	C,T	93,55	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	4236	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	208	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1604	Escherichia_coli_mutant_1	1359	1359	99.78	Escherichia_coli_mutant_1.l15.c4.ctg.1	1910	44.9	0	.	p	.	0	P9L	NONSYN	25	27	CCA	264	266	CTA	39;39;41	C;T;A	39;39;41	.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1604	Escherichia_coli_mutant_1	1359	1359	99.78	Escherichia_coli_mutant_1.l15.c4.ctg.1	1910	44.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1581	1583	AAA	42;42;42	A;A;A	42;42;42	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2448	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1885	69.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1337	1339	GAA	107;107;112	G;A;A	106;105;112	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	422	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	899	24.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	238	G	237	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	224	C	224	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	199	C	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	260	T	260	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	247	C	247	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	189	C	188	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	191	A	191	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	188	A	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	181	A	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	177	T,A	170,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	181	C	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	181	C	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	180	A,G	179,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	191	G	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	190	C	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	213	T	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	289	G	287	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	316	G	315	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	320	T	319	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	301	T	300	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	285	G	285	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	220	C	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	199	A	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	168	C	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	172	C	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	93	A	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	96	A	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	103	G	103	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	102	C	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	198	T	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	220	G	219	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	176	T,G	175,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	775	185.1	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	312	C	311	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T50C	SNP	50	50	T	191	191	C	89	C	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	G74A	SNP	74	74	G	215	215	A	25	A	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	G81.	DEL	81	81	G	221	221	A	27	A	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	A83C	SNP	83	83	A	223	223	C	29	C	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T93G	SNP	93	93	T	232	232	G	34	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T97C	SNP	97	97	T	236	236	C	36	C,A	35,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T128C	SNP	128	128	T	267	267	C	60	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T135A	SNP	135	135	T	274	274	A	71	A	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	G139C	SNP	139	139	G	278	278	C	74	C	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T142G	SNP	142	142	T	281	281	G	77	G	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	G159A	SNP	159	159	G	298	298	A	101	A	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	G161T	SNP	161	161	G	300	300	T	99	T	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	T168G	SNP	168	168	T	307	307	G	92	G	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	.	n	.	0	C170T	SNP	170	170	C	309	309	T	90	T	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	6372	Pasteurella_multocida_16S	1551	178	90.45	Pasteurella_multocida_16S.l15.c17.ctg.4	320	60.4	0	HET	.	.	.	C94T	.	94	94	C	233	233	C	33	C,T	8,25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1860	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1750	57.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	340	342	CGT	51;55;56	C;G;T	50;55;55	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1860	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1750	57.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1183	1185	GGC	75;77;78	G;G;C	75;77;78	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2574	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2218	62.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	300	302	AGC	36;37;38	A;G;C	36;37;38	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2574	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2218	62.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	702	704	CTA	72;74;75	C;T;A	71;74;75	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2574	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2218	62.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1221	1223	CAA	68;71;69	C;A;A	68;71;68	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2574	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2218	62.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1320	1322	GGT	70;73;72	G;G;T	70;73;71	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2574	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2218	62.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1890	1892	GTT	47;44;44	G;T;T	46;44;44	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	912	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1692	29.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	647	649	GAA	45;45;44	G;A;A	45;45;44	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	912	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1692	29.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	827	829	ACC	17;16;17	A;C;C	17;16;17	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	912	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1692	29.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	947	949	ACT	25;26;25	A;C;T	25;26;25	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	912	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1692	29.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1337	1339	ATC	18;18;19	A;T;C	18;18;19	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1288	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1566	44.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	528	62	acrB	3147	167	92.22	acrB.l6.c30.ctg.1	174	8.6	0	.	p	.	0	N146D	NONSYN	436	438	AAC	136	138	GAT	2;2;2	G;A;T	2;2;2	.	Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.;acrB
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3782	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3618	56.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	509	511	ATC	67;67;65	A;T;C	65;67;65	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3782	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3618	56.1	0	.	p	.	0	G549S	NONSYN	1645	1647	GGC	1901	1903	AGC	69;69;66	A;G;C	69;69;65	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3782	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3618	56.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2222	2224	AAG	47;49;49	A;A;G	47;49;49	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1690	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1716	53.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	289	291	GTC	30;28;24	G;T;C	29;27;23	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1690	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1716	53.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1030	1032	TGC	91;87;93	T;G;C	91;87;92	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	344	344	T	52	T	52	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	650	652	GAC	75;75;74	G;A;C	73;73;73	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	926	928	TTA	45;46;47	T;T;A	45;45;47	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2003	2005	AAT	79;80;81	A;A;T	78;80;81	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2117	2119	AGT	53;57;55	A;G;T	53;57;54	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2516	2518	GTG	63;62;62	G;T;G	63;62;61	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3071	3073	AAG	58;62;61	A;A;G	57;62;61	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	4750	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3641	69.9	0	HET	.	.	.	G186A	.	186	186	G	394	394	G	89	G,A	77,12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1082	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1223	47.3	1	SNP	p	R45C	0	.	.	133	135	CGC	424	426	CGC	80;79;84	C;G;C	80;79;84	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	1012	acrS	663	663	98.79	acrS.l6.c17.ctg.1	1188	45.6	0	.	p	.	0	L34F	NONSYN	100	102	CTC	319	321	TTC	46;47;47	T;T;C	46;47;47	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	1012	acrS	663	663	98.79	acrS.l6.c17.ctg.1	1188	45.6	0	.	p	.	0	E122G	NONSYN	364	366	GAG	583	585	GGG	48;48;45	G;G;G	48;48;45	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1358	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1358	53.9	0	.	p	.	0	V136L	NONSYN	406	408	GTT	716	718	CTT	84;84;83	C;T;T	83;84;83	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3454	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3260	56.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2228	2230	GCA	73;74;76	G;C;A	72;73;74	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3454	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3260	56.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2489	2491	ACC	50;53;55	A;C;C	49;52;55	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3454	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3260	56.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2798	2800	GCC	49;50;52	G;C;C	48;50;52	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	358	360	GCT	14;16;16	G;C;T	14;16;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	478	480	GAG	22;23;24	G;A;G	22;22;24	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	514	516	TGC	26;27;28	T;G;C	26;27;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	697	699	GTT	28;29;30	G;T;T	27;29;30	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	847	849	CAC	53;54;55	C;A;C	53;54;54	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1132	1134	ATG	49;49;50	A;T;G,A	47;49;49,1	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1872	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2292	42.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2128	2130	CGC	41;41;40	C;G;C	41;41;40	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1048	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1351	41.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	957	959	ACC	42;41;42	A;C;C	42;41;42	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1048	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1351	41.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	969	971	TCG	48;46;47	T;C;G	48;46;47	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	756	baeR	723	723	97.79	baeR.l6.c17.ctg.1	1355	30.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1296	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1956	35.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1395	1397	AAA	22;22;24	A;A;A	19;22;24	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1296	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1956	35.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1407	1409	GAG	27;28;29	G;A;G	27;27;28	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1296	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1956	35.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1413	1415	CAC	31;32;34	C;A;C	30;31;33	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1296	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1956	35.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1467	1469	GAG	37;35;34	G;A;G	37;35;34	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	2160	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1926	60.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1298	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1368	51.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	996	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1462	36.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1386	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1683	44.0	0	.	p	.	0	W42C	NONSYN	124	126	TGG	381	383	TGT	43;43;43	T;G;T	43;43;43	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1386	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1683	44.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	912	914	GTC	53;52;50	G;T;C	53;52;49	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	2148	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	2246	51.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1714	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1706	53.9	0	.	p	.	0	G209S	NONSYN	625	627	GGC	881	883	AGC	64;64;63	A;G;C	62;62;60	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	68	emrE_1	333	246	93.09	emrE_1.l15.c30.ctg.1	246	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1266	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1628	41.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	831	833	AGG	55;54;54	A;G;G	55;54;54	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1266	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1628	41.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1221	1223	GAC	35;34;34	G;A;C	35;34;34	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	922	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1153	42.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1932	emrY	1539	1539	99.81	emrY.l6.c30.ctg.1	2107	49.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	796	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1168	36.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	459	461	CTG	42;42;43	C;T;G	42;42;43	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	395	397	ATA	38;39;38	A;T;A	38;39;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	407	409	GTA	32;32;37	G;T;A	32;32;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	560	562	ACG	41;41;41	A;C;G	41;41;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	623	625	GAA	47;49;49	G;A;A	47;49;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	662	664	GCT	28;30;30	G;C;T	28;30;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	680	682	GAT	25;25;25	G;A;T	25;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	767	769	TCA	31;31;32	T;C;A	31;31;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	896	898	CAG	26;29;27	C;A;G	26;29;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1034	1036	GTT	35;34;33	G;T;T	35;34;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1190	1192	GAT	18;18;18	G;A;T	18;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1358	1360	AAT	19;19;19	A;A;T	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1379	1381	TTA	22;22;22	T;T;A,G	22;22;21,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1580	1582	AAA	28;28;28	A;A;A	28;28;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2315	2317	CAT	37;36;36	C;A;T	37;36;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2369	2371	CAT	47;49;47	C;A;T	47;49;47	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2387	2389	AGA	51;52;50	A;G;A	51;52;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2402	2404	AAT	50;51;50	A;A;T	50;51;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2549	2551	TCC	40;41;42	T;C;C	40;40;42	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2714	2716	ATT	44;45;44	A;T;T	44;45;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2735	2737	GAT	49;49;51	G;A;T	49;48;51	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2849	2851	GTT	50;50;49	G;T;T	50;48;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3134	3136	CAC	49;49;49	C;A;C	48;48;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3576	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4125	46.6	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	3872	3874	AAC	36;35;36	A;A;C	35;34;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1451	47.4	1	SNP	p	P64H	0	.	.	190	192	CCA	497	499	CCA	82;86;88	C;C;A	82;86;84	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1451	47.4	1	SNP	p	P64L	0	.	.	190	192	CCA	497	499	CCA	82;86;88	C;C;A	82;86;84	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1451	47.4	1	SNP	p	P64A	0	.	.	190	192	CCA	497	499	CCA	82;86;88	C;C;A	82;86;84	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1451	47.4	1	SNP	p	P64R	0	.	.	190	192	CCA	497	499	CCA	82;86;88	C;C;A	82;86;84	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1451	47.4	1	SNP	p	P64S	0	.	.	190	192	CCA	497	499	CCA	82;86;88	C;C;A	82;86;84	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	912	gadE	528	528	100.0	gadE.l6.c30.ctg.1	1163	41.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	L31V	NONSYN	91	93	CTG	15	17	GTG	2;2;2	G;T;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	D34E	NONSYN	100	102	GAT	24	26	GAG	2;2;2	G;A;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	L37V	NONSYN	109	111	TTG	33	35	GTG	2;2;2	G,T;T;G	0,1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	L46P	NONSYN	136	138	CTG	60	62	CCG	3;3;3	C;C;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	E54D	NONSYN	160	162	GAA	84	86	GAT	13;13;13	G;A;T	13;13;13	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	186	188	ATG	7;7;7	A;T;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	189	191	CCG	6;6;7	C;C;G	6;6;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	D100E	NONSYN	298	300	GAC	222	224	GAA	6;6;6	G;A;A	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	P101S	NONSYN	301	303	CCC	225	227	TCC	7;6;7	T;C;C	7;6;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	R102G	NONSYN	304	306	CGG	228	230	GGG	7;7;7	G;G;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	K110N	NONSYN	328	330	AAA	252	254	AAT	8;8;8	A;A;T	8;8;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	653	94.18	gadW.l15.c17.ctg.1	774	18.1	0	.	p	.	0	S234A	NONSYN	700	702	TCG	624	626	GCG	18;18;18	G;C;G	18;18;18	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1088	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1339	43.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	418	420	TTA	39;38;37	T;T;A	39;38;37	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1088	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1339	43.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	496	498	ATT	64;64;64	A;T;T	64;63;63	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1088	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1339	43.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	997	999	GGA	37;37;37	G;G;A	37;37;37	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1088	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1339	43.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1003	1005	CCG	31;30;30	C;C;G	31;30;30	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2253	2255	GAA	51;51;54	G;A;A	51;49;52	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	S83W	0	.	.	247	249	TCG	468	470	TCG	64;64;62	T;C;G	64;64;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	S83L	0	.	.	247	249	TCG	468	470	TCG	64;64;62	T;C;G	64;64;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	S83I	0	.	.	247	249	TCG	468	470	TCG	64;64;62	T;C;G	64;64;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	D87G	0	.	.	259	261	GAC	480	482	GAC	65;65;64	G;A,C;C	63;62,1;63	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	D87H	0	.	.	259	261	GAC	480	482	GAC	65;65;64	G;A,C;C	63;62,1;63	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	D87N	0	.	.	259	261	GAC	480	482	GAC	65;65;64	G;A,C;C	63;62,1;63	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	D87V	0	.	.	259	261	GAC	480	482	GAC	65;65;64	G;A,C;C	63;62,1;63	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3108	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3165	52.8	1	SNP	p	D87Y	0	.	.	259	261	GAC	480	482	GAC	65;65;64	G;A,C;C	63;62,1;63	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136G	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136C	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136I	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136E	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136L	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136H	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3946	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	3052	69.5	1	SNP	p	R136S	0	.	.	406	408	CGC	745	747	CGC	71;71;71	C;G;C	71;70;71	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	744	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1205	33.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	488	490	CCG	40;41;41	C;C;G	39;40;41	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	744	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1205	33.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	641	643	GCC	30;31;31	G;C;C	28;29;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1430	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1413	54.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	245	247	TCA	28;28;29	T;C;A	28;28;29	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	378	marA	384	384	99.74	marA.l6.c4.ctg.1	927	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	568	570	AGC	12;11;10	A;G;C	12;11;10	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	670	672	CAT	7;6;6	C,T;A,G;T	5,1;5,1;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	V45E	0	.	.	133	135	GTG	394	396	GTG	47;44;44	G;T;G	47;44;44	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	I49S	0	.	.	145	147	ATC	406	408	ATC	46;46;44	A;T;C	46;46;44	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	A70T	0	.	.	208	210	GCA	469	471	GCA	32;32;32	G;C;A,G	32;32;31,1	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	R73C	0	.	.	217	219	CGT	478	480	CGT	31;31;31	C;G;T	31;30;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	R73S	0	.	.	217	219	CGT	478	480	CGT	31;31;31	C;G;T	31;30;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	R77C	0	.	.	229	231	CGC	490	492	CGC	32;32;32	C;G;C	32;32;32	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	R77L	0	.	.	229	231	CGC	490	492	CGC	32;32;32	C;G;C	32;32;32	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	L78M	0	.	.	232	234	CTG	493	495	CTG	31;29;28	C;T;G	30;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	R94S	0	.	.	280	282	CGC	541	543	CGC	11;10;9	C;G;C	11;10;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	R94H	0	.	.	280	282	CGC	541	543	CGC	11;10;9	C;G;C	11;10;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	280	marR	435	435	97.7	marR.l15.c30.ctg.1	758	19.3	1	SNP	p	V96E	0	.	.	286	288	GTA	547	549	GTA	9;9;10	G;T;A	9;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	219	221	TTC	11;11;11	T;T;C	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	306	308	ATC	30;29;28	A;T;C	30;29;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	324	326	GCC	15;15;14	G;C;C	15;15;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	327	329	GTG	14;14;15	G;T;G	14;14;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	354	356	GAT	15;16;16	G;A;T	15;16;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	375	377	ACC	18;19;19	A;C;C	18;19;19	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	402	404	TTA	25;26;26	T;T;A	25;26;26	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	543	545	CAG	49;49;50	C;A;G	49;49;50	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	D128A	NONSYN	382	384	GAC	582	584	GCC	46;47;50	G;C;C	46;47;50	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	S163A	NONSYN	487	489	TCG	687	689	GCG	41;43;42	G;C;G	41;43;42	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	L231V	NONSYN	691	693	CTT	891	893	GTT	36;38;39	G;T;T	32;35;37	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1030	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1567	35.0	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1053	1053	C	35	C	35	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	998	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1939	27.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	335	335	G	27	G	27	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	998	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1939	27.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	392	394	CAG	28;26;23	C;A;G	27;25;22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	998	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1939	27.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	542	544	ATC	23;23;23	A;T;C	23;23;22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	998	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1939	27.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	590	592	ATG	26;26;27	A;T;G	26;26;27	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	998	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1939	27.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	683	685	ACC	26;26;25	A;C;C	25;26;25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1965	1967	ACC	42;40;41	A;C;C	42;40;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2358	2360	CAA	42;39;38	C;A;A	42;39;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2526	2528	ATT	40;40;43	A;T;T	38;40;43	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2610	2612	GTT	37;37;38	G;T;T	36;37;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2718	2720	GAG	35;36;37	G;A;G	35;35;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2946	2948	ATG	33;33;34	A;T;G	33;32;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3052	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3533	46.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3081	3083	GAT	49;50;52	G;A;T	48;50;51	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2734	mdtC	3078	3078	98.7	mdtC.l6.c17.ctg.1	3674	40.1	0	.	p	.	0	I46M	NONSYN	136	138	ATC	402	404	ATG	27;27;26	A;T;G	27;27;26	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2734	mdtC	3078	3078	98.7	mdtC.l6.c17.ctg.1	3674	40.1	0	.	p	.	0	V208I	NONSYN	622	624	GTC	888	890	ATC	35;36;36	A;T;C	35;34;36	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2734	mdtC	3078	3078	98.7	mdtC.l6.c17.ctg.1	3674	40.1	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3204	3206	CAC	19;19;19	C;A;C	17;18;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1422	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1926	39.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	183	185	GAA	39;38;38	G;A;A	39;38;38	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1422	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1926	39.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	852	854	GCG	49;48;47	G;C;G	49;48;47	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1422	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1926	39.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1194	1196	ATC	46;45;43	A;T;C	46;44;43	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1422	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1926	39.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1497	1499	TTT	53;54;57	T;T;T	53;54;57	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	2010	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1830	59.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4816	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3757	68.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1254	1256	ACC	71;72;72	A;C;C	71;69;71	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4816	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3757	68.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2496	2498	GAC	74;74;75	G;A;C	73;72;74	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1470	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1589	40.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	678	680	ATC	45;46;46	A;T;C	45;46;46	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1470	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1589	40.2	0	.	p	.	0	S340L	NONSYN	1018	1020	TCG	1098	1100	TTG	40;39;39	T;T;G	40;39;39	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1470	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	657	20.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	178	180	GGA	18;18;18	G;G;A	18;18;18	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1216	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1780	36.6	0	.	p	.	0	G134C	NONSYN	400	402	GGT	720	722	TGT	45;44;42	T;G;T	45;44;42	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1216	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1780	36.6	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1290	1292	TTG	49;47;48	T;T;G	49;47;48	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1216	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1780	36.6	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1500	1502	ACG	17;17;17	A;C;G	17;17;17	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1816	mdtL	1176	1176	98.21	mdtL.l15.c4.ctg.1	1695	57.3	0	.	p	.	0	A185S	NONSYN	553	555	GCC	798	800	TCC	50;50;52	T;C;C	48;50;52	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1294	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1660	41.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	671	673	ATT	26;27;27	A;T;T	25;26;25	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	297	299	ATG	39;38;38	A;T;G	38;38;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	363	365	ATC	35;33;35	A;T;C	35;32;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	612	614	CGC	68;68;69	C;G;C	68;67;68	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	978	980	AGC	76;74;75	A;G;C	76;73;75	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1179	1181	GTG	63;64;66	G;T;G	63;64;65	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1242	1244	AAC	32;28;28	A;A;C	29;23;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1287	1289	GTC	54;54;55	G;T;C	53;54;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1317	1319	ATA	71;71;71	A;T;A	71;71;71	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1425	1427	TCT	56;57;58	T;C;T	56;57;58	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1812	1814	GCG	64;64;64	G;C;G	64;63;63	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2796	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2627	57.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2025	2027	ATC	70;69;68	A;T;C	70;69;68	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	469	469	T	76	T,G	75,1	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	652	654	GCG	56;57;55	G;C;G	56;57;54	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	826	828	ACC	72;73;73	A;C;C	71;72;73	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	898	900	CGC	55;54;52	C;G;C	54;53;51	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1015	1017	GCT	49;50;51	G;C;T	48;50;51	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1099	1101	AAA	50;47;45	A;A;A	50;47;45	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1117	1119	CGA	50;53;55	C;G;A	50;53;54	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1282	1284	GCC	54;56;57	G;C;C	52;56;57	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1294	1296	GAT	60;61;64	G,A;A;T	58,1;60;64	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1838	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2023	48.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1711	1713	GCT	27;22;21	G;C;T	27;22;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3774	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3955	51.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1513	1515	AAG	48;48;50	A;A;G	48;48;50	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3774	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3955	51.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2590	2592	CTG	62;62;63	C;T;G	62;62;63	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	258	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	699	19.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2046	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2334	47.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1151	1153	AAC	35;33;32	A;A;C	35;33;32	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2046	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2334	47.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1697	1699	ATA	66;67;67	A;T;A	66;67;67	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1824	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1785	54.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1365	1367	GAT	80;80;79	G;A;T	80;77;79	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1824	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1785	54.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1368	1370	CTG	81;79;78	C;T;G	81;79;76	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	0	.	p	.	0	R27C	NONSYN	79	81	CGT	352	354	TGT	28;28;29	T;G;T	28;28;29	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	0	.	p	.	0	I117T	NONSYN	349	351	ATC	622	624	ACC	57;55;55	A;C;C	57;55;55	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	0	.	p	.	0	G187D	NONSYN	559	561	GGC	832	834	GAC	63;63;63	G;A;C	63;61;63	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	1	SNP	p	R15C	0	.	.	43	45	CGC	316	318	CGC	54;53;54	C;G;C	54;53;54	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	1	SNP	p	S33R	0	.	.	97	99	AGC	370	372	AGC	31;32;31	A;G;C	31;32;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	1	SNP	p	G131D	0	.	.	391	393	GGC	664	666	GGC	52;51;55	G;G;C	52;50;51	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	1	SNP	p	R203C	0	.	.	607	609	CGT	880	882	CGT	47;46;47	C;G;T	47;46;47	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	802	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1252	34.1	1	SNP	p	R203L	0	.	.	607	609	CGT	880	882	CGT	47;46;47	C;G;T	47;46;47	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1588	52.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1193	1195	GAG	75;74;75	G;A;G	75;74;75	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1588	52.1	1	SNP	p	G141D	0	.	.	421	423	GGT	680	682	GGT	73;74;76	G;G;T	71;74;74	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1588	52.1	1	SNP	p	G141E	0	.	.	421	423	GGT	680	682	GGT	73;74;76	G;G;T	71;74;74	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1588	52.1	1	SNP	p	R154D	0	.	.	460	462	CGT	719	721	CGT	71;70;70	C;G;T	71;70;70	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1588	52.1	1	SNP	p	R154A	0	.	.	460	462	CGT	719	721	CGT	71;70;70	C;G;T	71;70;70	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3390	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2736	66.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1886	1888	TCG	79;76;79	T;C;G,T	77;76;78,1	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3390	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2736	66.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2501	2503	AAC	42;42;42	A;A;C	40;42;42	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3390	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2736	66.5	1	SNP	p	A85T	0	.	.	253	255	GCG	515	517	GCG	72;73;72	G,T;C;G	70,1;72;72	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3390	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2736	66.5	1	SNP	p	D111H	0	.	.	331	333	GAT	593	595	GAT	66;62;64	G;A;T	66;61;63	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3390	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2736	66.5	1	SNP	p	S129P	0	.	.	385	387	TCC	647	649	TCC	77;76;76	T;C;C	76;76;76	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	2204	parE_1	1893	1893	97.57	parE_1.l15.c4.ctg.1	2548	46.4	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1737	1739	GAT	83;83;83	G;A;T	83;83;82	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2152	patA	1380	1380	99.86	patA.l15.c4.ctg.1	2051	56.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1383	1385	GAT	56;58;59	G;A;T	56;57;59	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	V146F	0	.	.	436	438	GTT	706	708	GTT	87;86;87	G;T;T	86;86;87	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1807	1809	CAG	102;104;100	C;A;G,T	101;103;99,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1807	1809	CAG	102;104;100	C;A;G,T	101;103;99,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1846	1848	CAC	87;85;86	C;A;C	87;84;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1855	1857	CGT	81;80;83	C;G;T	81;80;83	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1855	1857	CGT	81;80;83	C;G;T	81;80;83	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1861	1863	TCC	76;79;79	T;C;C	75;79;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1867	1869	CTC	77;76;76	C;T;C	76;74;75	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1957	1959	ACC	94;95;94	A;C;C	93;95;93	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1960	1962	CCT	91;90;85	C;C;T	91;90;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6922	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4482	82.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2329	2331	CGT	108;108;105	C;G;T	108;108;104	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	126	94.49	rrsB+.l15.c17.ctg.1	126	93.5	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	163	A	163	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	126	94.49	rrsB+.l15.c17.ctg.1	126	93.5	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	169	C	169	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	126	94.49	rrsB+.l15.c17.ctg.1	126	93.5	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	172	C	171	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	126	94.49	rrsB+.l15.c17.ctg.1	126	93.5	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	172	G	172	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	126	94.49	rrsB+.l15.c17.ctg.1	126	93.5	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	173	G	173	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	126	94.49	rrsB+.l15.c17.ctg.1	126	93.5	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	133	T	133	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	564.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	454	A,C	449,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	564.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	454	A,C	449,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	564.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	454	A,C	449,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	.	n	.	0	A226G	SNP	226	226	A	367	367	G	543	G	538	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	1	SNP	n	A794T	0	.	.	794	794	A	935	935	A	563	A,C	554,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	1	SNP	n	A794G	0	.	.	794	794	A	935	935	A	563	A,C	554,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	1	SNP	n	G926A	0	.	.	926	926	G	1067	1067	G	499	G	495	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	1	SNP	n	G926T	0	.	.	926	926	G	1067	1067	G	499	G	495	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	1	SNP	n	G926C	0	.	.	926	926	G	1067	1067	G	499	G	495	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	C719T	.	719	719	C	860	860	C	520	C,T	275,243	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	C183T	.	183	183	C	324	324	C	553	C,T	369,179	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	A250T	.	250	250	A	391	391	A	496	A,T	387,108	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	T90C	.	90	90	T	231	231	T	504	T,C	337,162	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	G474A	.	474	474	G	615	615	G	537	G,A	403,129	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	A253T	.	253	253	A	394	394	A	500	A,T	390,104	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	C194T	.	194	194	C	335	335	C	542	C,T	438,99	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	A79G	.	79	79	A	220	220	A	489	A,G	326,162	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.3	1142	498.6	0	HET	.	.	.	T273A	.	273	273	T	414	414	T	504	T,A	380,116	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17996	rrsB+	1542	141	100.0	rrsB+.l15.c17.ctg.5	141	163.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	880	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1050	45.2	1	SNP	p	R20H	0	.	.	58	60	CGC	368	370	CGC	85;83;85	C;G;C	84;83;85	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	880	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1050	45.2	1	SNP	p	G121D	0	.	.	361	363	GGT	671	673	GGT	72;72;73	G;G;T	72;72;73	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	656	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	976	35.9	1	SNP	p	A12S	0	.	.	34	36	GCA	397	399	GCA	80;80;80	G;C;A	80;80;80	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2318	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2175	57.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
